Validair Launches New Company in Ireland
The new company has been appointed as a channel partner for Ireland by TSI Inc., a particle counter manufacturer.
Validair announced on May 1, 2022 that it has formed a new company that has been appointed as a channel partner for Ireland by TSI Inc., a particle counter manufacturer and contamination control company. The agreement will allow Validair Monitoring Ireland Limited to deliver services across Ireland from its headquarters in Dublin. The new company will offer the entire TSI range of products and access to more than 20 field service and specialist technical engineers in the pharmaceutical, life sciences, biotech and research, and healthcare markets.
“Validair companies have demonstrated impressive capabilities with more than 120 TSI systems installed in the [United Kingdom] over the past 20 years, including the largest-ever global installation at Oxford Biomedica. We are very confident that the new venture will deliver the same excellent level of results that Validair customers in other territories have come to expect,” said Simon Tebb, sales manager EMEA Controlled Environments at TSI Inc., in a press release.
Source: Validair
MHRA Approves GSK Therapy Combinations for Multiple Myeloma
April 21st 2025Belantamab mafodotin is approved in combination with bortezomib plus dexamethasone in patients who have had at least one prior therapy, and in combination with pomalidomide plus dexamethasone for those who have had a prior therapy including lenalidomide.
